Clinical Trial Update: Placebo-controlled Trial With Vitamin D to Prevent Worsening/Relieve Aromatase Inhibitor-induced Musculoskeletal Symptoms in Breast Cancer Patients [Phase 2, Phase 3]

View source ↗

Summary

A placebo-controlled phase 2/3 trial evaluating whether vitamin D can prevent or relieve aromatase inhibitor-induced musculoskeletal symptoms in breast cancer p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Breast Cancer, Musculoskeletal Disease | Phase 2, Phase 3 | Status: TERMINATED